These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 3178314)

  • 21. Subclavian and axillary involvement in temporal arteritis and polymyalgia rheumatica.
    Ninet JP; Bachet P; Dumontet CM; Du Colombier PB; Stewart MD; Pasquier JH
    Am J Med; 1990 Jan; 88(1):13-20. PubMed ID: 2294760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Giant-cell arteritis, temporal arteritis and polymyalgia rheumatica. A retrospective study of 63 patients.
    Sorensen S; Lorenzen I
    Acta Med Scand; 1977; 201(3):207-13. PubMed ID: 848358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment and prognosis in polymyalgia rheumatica and temporal arteritis. A ten-year survey of 53 patients.
    von Knorring J
    Acta Med Scand; 1979; 205(5):429-35. PubMed ID: 443084
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of polymyalgia rheumatica/giant cell arteritis.
    Kyle V
    Baillieres Clin Rheumatol; 1991 Dec; 5(3):485-91. PubMed ID: 1807823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognosis and management of polymyalgia rheumatica.
    Jones JG; Hazleman BL
    Ann Rheum Dis; 1981 Feb; 40(1):1-5. PubMed ID: 7469518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
    Unizony S; Arias-Urdaneta L; Miloslavsky E; Arvikar S; Khosroshahi A; Keroack B; Stone JR; Stone JH
    Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1720-9. PubMed ID: 22674883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis.
    Jakobsson K; Jacobsson L; Mohammad AJ; Nilsson JÅ; Warrington K; Matteson EL; Turesson C
    BMC Musculoskelet Disord; 2016 Aug; 17(1):363. PubMed ID: 27558589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and laboratory findings with giant cell arteritis.
    Berlit P
    J Neurol Sci; 1992 Aug; 111(1):1-12. PubMed ID: 1402990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adrenal insufficiency in prednisolone-treated patients with polymyalgia rheumatica or giant cell arteritis-prevalence and clinical approach.
    Borresen SW; Thorgrimsen TB; Jensen B; Hilsted L; Bartels EM; Feldt-Rasmussen U; Locht H
    Rheumatology (Oxford); 2020 Oct; 59(10):2764-2773. PubMed ID: 32031663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Musculoskeletal manifestations in polymyalgia rheumatica and temporal arteritis.
    Narváez J; Nolla-Solé JM; Narváez JA; Clavaguera MT; Valverde-García J; Roig-Escofet D
    Ann Rheum Dis; 2001 Nov; 60(11):1060-3. PubMed ID: 11602480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymyalgia rheumatica and temporal arteritis: managing older patients.
    Pereira M; Kaine JL
    Geriatrics; 1986 Jun; 41(6):54-5, 59-60, 63 passim. PubMed ID: 3710167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymyalgia rheumatica and giant cell arteritis. Avoiding management traps.
    de Jager JP
    Aust Fam Physician; 2001 Jul; 30(7):643-7. PubMed ID: 11558196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a 10 year study.
    González-Gay MA; García-Porrúa C; Vázquez-Caruncho M; Dababneh A; Hajeer A; Ollier WE
    J Rheumatol; 1999 Jun; 26(6):1326-32. PubMed ID: 10381051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Polymyalgia rheumatica].
    Nishikai M
    Nihon Rinsho; 1999 Feb; 57(2):370-3. PubMed ID: 10078007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal failure in temporal arteritis.
    Canton CG; Bernis C; Paraiso V; Barril G; García A; Osorio C; Rincón B; Traver JA
    Am J Nephrol; 1992; 12(5):380-3. PubMed ID: 1489011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognosis of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. A follow-up study on ninety patients treated with corticosteroids.
    Bengtsson BA; Malmvall BE
    Acta Med Scand; 1981; 209(5):337-45. PubMed ID: 7246269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Polymyalgia rheumatica and its treatment].
    Mumenthaler M
    Dtsch Med Wochenschr; 1974 Sep; 99(36):1774-5. PubMed ID: 4141305
    [No Abstract]   [Full Text] [Related]  

  • 38. Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?
    van der Veen MJ; Dinant HJ; van Booma-Frankfort C; van Albada-Kuipers GA; Bijlsma JW
    Ann Rheum Dis; 1996 Apr; 55(4):218-23. PubMed ID: 8733437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recognition of giant cell arteritis in patients with polymyalgia rheumatica who have a stroke: a cautionary tale.
    Gutteridge DH; Mastaglia FL
    Intern Med J; 2017 Oct; 47(10):1199-1201. PubMed ID: 28994265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibrin(ogen)olysis in polymyalgia rheumatica and temporal arteritis: preliminary findings on association with disease activity.
    Grau RG; Kassan SS; Franks JJ; Kaplan H; Walker SH; Tan EM
    Ann Rheum Dis; 1984 Oct; 43(5):721-4. PubMed ID: 6497463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.